Welcome to our dedicated page for Rocket Lab Usa SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Rocket Lab Corporation (Nasdaq: RKLB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a U.S. public company. These documents include current reports on Form 8-K, proxy statements, and other filings that describe material events, governance matters, capital markets activity, and acquisitions.
Rocket Lab’s Form 8-K filings cover topics such as quarterly financial results, executive and director changes, equity offering arrangements, and significant transactions. Examples include reports of results of operations for specific quarters, the adoption of a senior executive cash incentive bonus plan, the establishment of an at-the-market equity offering program under a shelf registration statement, and the completion or announcement of acquisitions such as the purchase of the parent holding company of GEOST LLC and an agreement to acquire all shares of Mynaric AG.
The company’s proxy statement on Form DEF 14A provides detail on board structure, director elections, executive compensation, equity plans, and stockholder voting matters. It also describes the holding company reorganization that made Rocket Lab Corporation the parent of Rocket Lab USA, Inc., and outlines proposals presented to stockholders at the annual meeting.
Through these filings, investors can review information about capital raising (including at-the-market offerings), governance and compensation policies, acquisition terms, and other material corporate events. Real-time updates from EDGAR allow users to see new 8-Ks and related exhibits as they are filed.
Stock Titan’s platform associates these filings with AI-powered summaries that explain the key points of lengthy documents, helping users quickly identify items such as new financing arrangements, changes in leadership, or the structure of significant transactions. Users can also track how Rocket Lab uses registration statements and resale prospectus supplements in connection with share issuances tied to acquisitions.
Rocket Lab Corporation describes itself as an end-to-end space company providing small-launch services, spacecraft, components, and on-orbit solutions. Its Electron rocket has completed 75 successful missions through December 31, 2025, deploying over 200 spacecraft, and in 2025 was the second most frequently launched orbital rocket.
The company is developing its larger Neutron launch vehicle, expanding space systems offerings (including solar power, reaction wheels, star trackers and optical systems), and integrating several acquisitions. Revenue grew to $601.8 million in 2025 from $436.2 million in 2024 and $244.6 million in 2023, but Rocket Lab recorded net losses of $198.2 million, $190.2 million and $182.6 million in those years.
As of December 31, 2025, Rocket Lab had over 2,600 employees and operated multiple facilities in the United States, New Zealand and Canada, including dedicated launch complexes in Mahia, New Zealand and Wallops Island, Virginia. The filing highlights extensive risk factors, including dependence on a few major customers, U.S. government funding and policy, technology development and launch failures, supply-chain disruption, cybersecurity, competition, and the need for additional capital.
Rocket Lab Corporation reported record results for the fourth quarter and full year 2025. The company posted record quarterly revenue of
Rocket Lab achieved a new annual launch record with 21 Electron and HASTE missions at a 100% success rate and advanced development of its Neutron medium-lift rocket, now targeting a first launch in Q4 2026 after schedule updates. Despite strong growth, the company recorded a 2025 net loss of
For Q1 2026, Rocket Lab guides to record quarterly revenue between
Rocket Lab Corporation’s major shareholder VK Services, LLC and Vinod Khosla updated their ownership disclosure. They report beneficial ownership of 34,888,272 shares of Rocket Lab common stock, representing 6.5% of the 534,156,333 shares outstanding as referenced in the filing.
The filing explains that these shares trace back to preferred stock investments in Legacy Rocket Lab made between 2013 and 2020 for approximately $28.2 million, which converted into common stock in the August 2021 business combination with Vector Acquisition Corporation. VK Services now directly owns the shares, while KVA V no longer holds any.
The reporting persons state the stake is held for investment purposes and that they currently have no specific plans to change Rocket Lab’s business, management or capital structure. However, they reserve the right to buy or sell shares and to use registration rights that allow underwritten offerings and piggyback registrations under a Second Amended and Restated Registration Rights Agreement.
Rocket Lab Corp director Jon A. Olson reported selling a total of 15,205 shares of common stock on January 20, 2026, in multiple open-market transactions at weighted-average prices ranging from about $89.02 to $97.92 per share.
The sales occurred automatically under a Rule 10b5-1 trading plan that Olson adopted on September 19, 2025. Following these transactions, he beneficially owns 345,630 Rocket Lab shares, held directly.
Rocket Lab Corporation filed an update on the development of its Neutron rocket following a qualification test incident. During a hydrostatic pressure trial, the Stage 1 tank ruptured, and the company’s team is now reviewing the Stage 1 test data. The outcome of this review will determine how much Neutron’s launch schedule is affected. The company communicated these details in a press release furnished as an exhibit, emphasizing that this information is provided for disclosure purposes and is not incorporated into other securities filings unless specifically referenced.
Rocket Lab Corp director Merline Saintil reported two stock transactions. On January 13, 2026, the reporting person disposed of 96,000 shares of common stock at $86.58 per share by contributing the shares to an exchange fund in return for shares of that fund. On January 14, 2026, the reporting person sold 12,500 shares of common stock at $90 per share, in a sale that occurred automatically under a Rule 10b5-1 trading plan adopted on September 17, 2025. Following these transactions, the reporting person directly owned 280,029 shares of Rocket Lab common stock.
A shareholder of RKLB, Merline A. Saintil, has filed a Rule 144 notice to sell 12,500 shares of RKLB common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $1,082,250 for these shares and 534,156,333 common shares outstanding overall. The 12,500 shares were acquired from the issuer on August 22, 2023 as restricted stock units.
Over the prior three months, the same shareholder reported several sales of RKLB common stock, including multiple Rule 10b5-1 plan transactions in December 2025. These past sales ranged from 5,000 to 15,000 shares per transaction, with disclosed gross proceeds for each sale. The filing also includes a representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Rocket Lab Corp’s Chief Financial Officer, Adam Spice, reported an option exercise and share sales. On January 5, 2026, he exercised 731,330 Employee Stock Options at an exercise price of $1.09 per share, receiving the same number of Rocket Lab common shares.
On the same date, he sold multiple blocks of Rocket Lab common stock in open-market transactions at weighted-average prices ranging from $72.149 to $78.0435 per share under a pre-established Rule 10b5-1 trading plan adopted on September 19, 2025. Following these transactions, he directly owned 1,359,568 shares of common stock and 2,522,825 stock options.
Rocket Lab Corp director Merline Saintil reported multiple stock sales carried out under a pre-arranged Rule 10b5-1 trading plan. On December 17, 2025, she sold blocks of 2,533, 1,767, 500 and 200 shares of Rocket Lab common stock in open-market transactions.
The reported weighted-average sale prices were $53.8164, $54.824, $55.668 and $56.48, with each group of trades executed across price ranges detailed in the footnotes. After these transactions, Saintil directly beneficially owned 393,529 shares of Rocket Lab common stock.
The filing notes that these sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Rocket Lab Corp reported insider stock sales by CEO and director Peter Beck, executed indirectly through the Equatorial Trust on December 15 and 16, 2025. The sales occurred automatically under a Rule 10b5-1 trading plan adopted by the trust on June 13, 2025.
The trust sold multiple blocks of Rocket Lab common stock, including 317,989 shares at a weighted-average price of